Ibane Abasolo
@ibane-abasolo.bsky.social
Research scientist at IQAC-CSIC. Nanomedicine, extracellular vesicles and other nice stuff. Always searching for answers.
Proyectos como ReachGlio y CancerScan, financiadas por la AECC, @isciiisalud.bsky.social y la Unión Europea son un ejemplo cómo, investigando se puede avanzar hacia terapias más eficaces y personalizadas.
#WorldCancerDay #CancerResearch
#IQAC #CSIC #CIBERBBN #NM4T #ReachGlio #CancerScan
#WorldCancerDay #CancerResearch
#IQAC #CSIC #CIBERBBN #NM4T #ReachGlio #CancerScan
February 4, 2026 at 12:27 PM
Proyectos como ReachGlio y CancerScan, financiadas por la AECC, @isciiisalud.bsky.social y la Unión Europea son un ejemplo cómo, investigando se puede avanzar hacia terapias más eficaces y personalizadas.
#WorldCancerDay #CancerResearch
#IQAC #CSIC #CIBERBBN #NM4T #ReachGlio #CancerScan
#WorldCancerDay #CancerResearch
#IQAC #CSIC #CIBERBBN #NM4T #ReachGlio #CancerScan
July 4, 2025 at 5:33 PM
Thanks also to the incredible committee: Maria Sancho, Victor J. Lopez & Julia Lorenzo, for their insightful discussion and the time they generously dedicated to Marc’s work.
July 4, 2025 at 5:33 PM
Thanks also to the incredible committee: Maria Sancho, Victor J. Lopez & Julia Lorenzo, for their insightful discussion and the time they generously dedicated to Marc’s work.
Please share the feed with friends and colleagues or directly email me if you are interested. [email protected]
March 20, 2025 at 7:30 AM
Please share the feed with friends and colleagues or directly email me if you are interested. [email protected]
We are applying to three competitive PhD funding calls.
o CSIC’s JAE INTRO and JAE ICU’s grants. Short-term fellowships (5–7 months) designed to help candidates preparing applications for longer-term PhD funding opportunities.
o AGAUR’s FI-STEP call, funding PhD candidates for 3 years.
o CSIC’s JAE INTRO and JAE ICU’s grants. Short-term fellowships (5–7 months) designed to help candidates preparing applications for longer-term PhD funding opportunities.
o AGAUR’s FI-STEP call, funding PhD candidates for 3 years.
March 20, 2025 at 7:30 AM
We are applying to three competitive PhD funding calls.
o CSIC’s JAE INTRO and JAE ICU’s grants. Short-term fellowships (5–7 months) designed to help candidates preparing applications for longer-term PhD funding opportunities.
o AGAUR’s FI-STEP call, funding PhD candidates for 3 years.
o CSIC’s JAE INTRO and JAE ICU’s grants. Short-term fellowships (5–7 months) designed to help candidates preparing applications for longer-term PhD funding opportunities.
o AGAUR’s FI-STEP call, funding PhD candidates for 3 years.
Selected candidates will participate in one of the following projects:
1. Production and evaluation of extracellular vesicles for the enzyme replacement therapies in lysosomal storage disorders.
2. Development of targeted biodegradable nanomedicines for the treatment of cancer
#Cancer #LSDs #EVs
1. Production and evaluation of extracellular vesicles for the enzyme replacement therapies in lysosomal storage disorders.
2. Development of targeted biodegradable nanomedicines for the treatment of cancer
#Cancer #LSDs #EVs
March 20, 2025 at 7:30 AM
Applicants must
- Be citizens of an EU country
- Have obtained already or be on track to complete a Master’s degree in biomedical sciences by Sept 15, 2025
- Have a strong academic record (GPA > 8/10)
#Nanomedicine #DrugDelivery #BiomedicalResearch #PhDopportunity #Barcelona #IQAC #CSIC
- Be citizens of an EU country
- Have obtained already or be on track to complete a Master’s degree in biomedical sciences by Sept 15, 2025
- Have a strong academic record (GPA > 8/10)
#Nanomedicine #DrugDelivery #BiomedicalResearch #PhDopportunity #Barcelona #IQAC #CSIC
March 20, 2025 at 7:30 AM
Applicants must
- Be citizens of an EU country
- Have obtained already or be on track to complete a Master’s degree in biomedical sciences by Sept 15, 2025
- Have a strong academic record (GPA > 8/10)
#Nanomedicine #DrugDelivery #BiomedicalResearch #PhDopportunity #Barcelona #IQAC #CSIC
- Be citizens of an EU country
- Have obtained already or be on track to complete a Master’s degree in biomedical sciences by Sept 15, 2025
- Have a strong academic record (GPA > 8/10)
#Nanomedicine #DrugDelivery #BiomedicalResearch #PhDopportunity #Barcelona #IQAC #CSIC
My kudos to Gio Lerussi and Vero Villagrasa. You've done amaizing job with this review!! 👏
January 29, 2025 at 7:47 AM
My kudos to Gio Lerussi and Vero Villagrasa. You've done amaizing job with this review!! 👏
This review compiles ALL published work on using EVs as drug delivery systems for improving the enzyme replacement therapy in disease such Fabry, Gauche, Batten, cystynosis and many others.
If you want to know more about LSDs, EVs or protein delivery, this IS your paper.
If you want to know more about LSDs, EVs or protein delivery, this IS your paper.
January 29, 2025 at 7:47 AM
This review compiles ALL published work on using EVs as drug delivery systems for improving the enzyme replacement therapy in disease such Fabry, Gauche, Batten, cystynosis and many others.
If you want to know more about LSDs, EVs or protein delivery, this IS your paper.
If you want to know more about LSDs, EVs or protein delivery, this IS your paper.
This was a huge collaborative work with groups form This collaborative effort includes contributions from VHIR, CIBER-BBN, IMDEA, TC Dublin, RCL...
It’s always a pleasure to collaborate with such excellent partners and friends! 👩🔬
It’s always a pleasure to collaborate with such excellent partners and friends! 👩🔬
January 9, 2025 at 2:46 PM
This was a huge collaborative work with groups form This collaborative effort includes contributions from VHIR, CIBER-BBN, IMDEA, TC Dublin, RCL...
It’s always a pleasure to collaborate with such excellent partners and friends! 👩🔬
It’s always a pleasure to collaborate with such excellent partners and friends! 👩🔬
Our findings highlight the synergistic effect of combining chemotherapy 💊with hyperthermia 🔥, enhancing therapeutic efficacy through the disruption of tumor stroma and direct action on cancer cells. Results were essential for the approval of the first clinical study using MNP in pancreatic cancer
January 9, 2025 at 2:46 PM
Our findings highlight the synergistic effect of combining chemotherapy 💊with hyperthermia 🔥, enhancing therapeutic efficacy through the disruption of tumor stroma and direct action on cancer cells. Results were essential for the approval of the first clinical study using MNP in pancreatic cancer